TY - JOUR
T1 - p16INK4a overexpression and human papillomavirus infection in small cell carcinoma of the uterine cervix
AU - Masumoto, Nobuo
AU - Fujii, Takuma
AU - Ishikawa, Mitsuya
AU - Saito, Miyuki
AU - Iwata, Takashi
AU - Fukuchi, Takeshi
AU - Susumu, Nobuyuki
AU - Mukai, Makio
AU - Kubushiro, Kaneyuki
AU - Tsukazaki, Katsumi
AU - Nozawa, Shiro
N1 - Funding Information:
Supported in part by a Grant-in-Aid for Scientific Research (A) for Japanese Society for the promotion of Science and Research Grants for Life Science and Medicine, the Keio University Medical Science Fund, and by a Grant-in-Aid for Scientific Research on Priority Area (C) in 2000–2003 from the Ministry of Education, Science, Sports, Culture, and Technology in Japan.
PY - 2003/9/1
Y1 - 2003/9/1
N2 - Carcinogenesis of cervical cancer has been investigated, and p16 INK4a overexpression in squamous cell carcinoma of the cervix has been reported as a result of infection by human papillomavirus (HPV) (eg, HPV 16), and the consequence of the retinoblastoma (Rb) protein inactivation by HPV E7 protein. However, to our knowledge, there have been no studies on the relation between p16INK4a overexpression associated with HPV and small cell carcinoma of the cervix, which behaves more aggressively clinically than squamous cell carcinoma. The purpose of this study was to determine whether p16INK4a is overexpressed in small cell carcinoma, and if p16INK4a is overexpressed, the types of HPV that are related to this cancer. We reviewed 10 cases of small cell carcinoma and examined them for p16INK4a overexpression by immunohistochemistry. We also performed HPV typing with polymerase chain reaction (PCR)-sequencing analysis and in situ hybridization and found that p16INK4a was overexpressed in every case. PCR-sequencing analyses revealed that all cases were HPV-positive and that 9 cases were positive for HPV 18. Five of the 9 cases positive for HPV 18 were also positive by in situ hybridization and yielded a punctate signal, considered to represent the integrated form. In conclusion, p16INK4a was overexpressed and HPV 18 was frequently detected in an integrated form in small cell carcinoma. Therefore, inactivation of Rb protein by HPV 18 E7 protein may be associated with carcinogenesis of small cell carcinoma the same as inactivation of Rb protein by HPV 16 E7 protein is associated with carcinogenesis of squamous cell carcinoma.
AB - Carcinogenesis of cervical cancer has been investigated, and p16 INK4a overexpression in squamous cell carcinoma of the cervix has been reported as a result of infection by human papillomavirus (HPV) (eg, HPV 16), and the consequence of the retinoblastoma (Rb) protein inactivation by HPV E7 protein. However, to our knowledge, there have been no studies on the relation between p16INK4a overexpression associated with HPV and small cell carcinoma of the cervix, which behaves more aggressively clinically than squamous cell carcinoma. The purpose of this study was to determine whether p16INK4a is overexpressed in small cell carcinoma, and if p16INK4a is overexpressed, the types of HPV that are related to this cancer. We reviewed 10 cases of small cell carcinoma and examined them for p16INK4a overexpression by immunohistochemistry. We also performed HPV typing with polymerase chain reaction (PCR)-sequencing analysis and in situ hybridization and found that p16INK4a was overexpressed in every case. PCR-sequencing analyses revealed that all cases were HPV-positive and that 9 cases were positive for HPV 18. Five of the 9 cases positive for HPV 18 were also positive by in situ hybridization and yielded a punctate signal, considered to represent the integrated form. In conclusion, p16INK4a was overexpressed and HPV 18 was frequently detected in an integrated form in small cell carcinoma. Therefore, inactivation of Rb protein by HPV 18 E7 protein may be associated with carcinogenesis of small cell carcinoma the same as inactivation of Rb protein by HPV 16 E7 protein is associated with carcinogenesis of squamous cell carcinoma.
UR - http://www.scopus.com/inward/record.url?scp=0141705411&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0141705411&partnerID=8YFLogxK
U2 - 10.1016/S0046-8177(03)00284-3
DO - 10.1016/S0046-8177(03)00284-3
M3 - Article
C2 - 14506638
AN - SCOPUS:0141705411
SN - 0046-8177
VL - 34
SP - 778
EP - 783
JO - Human Pathology
JF - Human Pathology
IS - 8
ER -